# Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure

> **NCT04980170** · EARLY_PHASE1 · UNKNOWN · sponsor: **Jordan University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Antibiotics Causing Adverse Effects in Therapeutic Use

## Interventions

- **DRUG:** Clindamycin 300 mg
- **DRUG:** Amoxicillin with Clavulanic Acid 635mg

## Key facts

- **NCT ID:** NCT04980170
- **Lead sponsor:** Jordan University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-06-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04980170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04980170, "Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04980170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*